Richard Gray, M.D.’s Post

Why programs that focus on lung health are very effective - Drew Moghanaki, MD, MPH https://lnkd.in/gtdsm8zp #oncodaily #oncology #cancer #LungHealth #PublicHealth #HealthAwareness #LungCancerPrevention #HealthPrograms

𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? According to The National Institutes of Health, liver cancer is the sixth most common cancer and the third leading cause of cancer death. Techsomed is dedicated to making an enhanced clinical impact in liver tumor ablation through our innovative, #AI-powered Image-Guided #Ablation Therapy (IGAT) platform. Join me in raising awareness for liver cancer this October! #LiverCancerAwarnessMonth, #LiverCancer, #HepatocellularCarcinoma #OctoberIs4Livers

𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? According to The National Institutes of Health, liver cancer is the sixth most common cancer and the third leading cause of cancer death. Techsomed is dedicated to making an enhanced clinical impact in liver tumor ablation through our innovative, #AI-powered Image-Guided #Ablation Therapy (IGAT) platform. Join us in raising awareness for liver cancer this October! #LiverCancerAwarnessMonth, #LiverCancer, #HepatocellularCarcinoma #OctoberIs4Livers

What difference can The CARE Program™ make for a practice that wants to identify patients at increased risk for cancer? Her Healthcare in Houston, TX, found that in just eight months, more than 200 patients qualified for hereditary cancer testing and more than 300 patients have qualified for increased breast cancer screening based on their medical/family history via breast cancer risk score calculation. Read more in our two-part blog series as Dr. Boyd explains the benefits of identifying patients at increased risk for cancer and how it affects treatment, screening and preventive recommendations. Part One: https://hubs.ly/Q01-QDsT0 Part Two: https://hubs.ly/Q01-QCtl0 #CARE #hereditarycancertesting

"...it is reasonable for clinicians to now consider #germline #genetictesting for all #patients diagnosed with #LungCancer." 14.3% of #lungcancer #patients w/o #cancer #familyhistory or other personal #cancer history have pathogenic germline variants (PGVs) s w/ #germlinetesting, Steven Sorscher et al. in #JCOPO @ American Society of Clinical Oncology (ASCO) Jaclyn LoPiccolo, Brandie Leach, Elaine Chen, Sara Bristow, PhD, Michalski Scott, Sarah Young (Nielsen), Alix Lacoste, Emil Keyder, Hayan Lee, Robert Nussbaum, MD, #DrRenatoMartins, Dana-Farber Cancer Institute, VCU Massey Comprehensive Cancer Center, Invitae #LCSM #lungcancerawarenessmonth #LCAM #access #reducedisparities #universaltesting #precisionmedicine #precisiontherapy #clinicaltrials #precisionprevention https://lnkd.in/gE5y3cg5

With November being Lung Cancer Awareness Month, it’s important to remember the importance of lung screening in early detection and later prognosis. Research shows that only 5-6% of patients eligible for lung screening are screened. Grassroots and community efforts to raise awareness on this are important to increase these numbers - both to inform patients that lung screening is available and how it can help them. #lungcancer #lungcancerawarenessmonth #lungscreening

We’re spotlighting the crucial need for early detection. Lung cancer is the leading cause of cancer-related deaths in Canada, accounting for nearly 25%. 🫁 Discover how we're making a difference with targeted screening initiatives and proactive awareness campaigns. Let’s move towards a future where lung cancer is diagnosed early and treated effectively: https://ow.ly/nMXt50SOxVg #WorldLungCancerDay #LungHealth #EarlyDetection

DID YOU KNOW: Lung cancer ranks third in U.S. cancer cases. Awareness is key in the fight against this disease. This statistic highlights the importance of early detection through screenings. Find out how we can help. https://lnkd.in/euUm5RUc #IntegraHealth #PulmonaryCare #LungCancerTreatment

Despite progress in treatment, #LungCancer remains the leading cause of cancer mortality, accounting for about one in five of all cancer deaths. Through the ongoing development of our investigational chemotherapy-free combination regimen for non-small cell lung cancer we are working to redefine what a diagnosis means for patients. Read more about results from our Phase 3 MARIPOSA study recently published in the NEJM Group, highlighting our dedication to transforming #NSCLC care: https://lnkd.in/eZHSM3qF #JNJOncology

“People are waiting far too long for diagnosis and to start treatment, with cancer waiting time targets consistently being missed”. In this article, we are reminded of the significance of investments and funding into the healthcare industry, as well as the pressures to diagnose at the earliest stages. With cancer cases forecasted to rise, funding and early diagnosis is crucial to bettering outcomes and increasing survival rates. CanSense’s CRC test can save more lives, through the early detection of bowel cancer. #CanSense #BowelCancer #EarlyDetection #EarlyDectionOfCancer #EarlyDetectionOfBowelCancer https://lnkd.in/eqDAGQFW